Delivery Order SPE2DR25D1053-SPE2DR26FT670
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 MG tablets (60-count packages) under a firm fixed-price contract with a ceiling value of $3,931.20. The award, announced on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count packaging) valued at $11,679.67 under a firm fixed-price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 2.5 mg tablets in a 60-count package, valued at $1,474.20 under a firm fixed-price contract. This non-set-aside award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,768.30 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count supply) valued at $17,735.23. This firm fixed-price contract, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) under a firm fixed price contract. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement and is issued as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,358.13 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 5 mg tablets (60-count units) under a firm fixed price contract. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $82,455.67 for ELIQUIS 5 mg tablets (60-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) valued at $4,289.88. This is a competitively awarded, non-set-aside firm fixed-price contract with an ultimate completion date of June 9, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,965.60. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...